Literature DB >> 23275788

A Case of Candida albicans Endophthalmitis with No Predisposing Risk Factors and a Distant Source of Infection.

Randhir Chavan1, Mohammad Z Mustafa, Nirodhini Narendran, Shoaib Tarin, Yit Yang.   

Abstract

PURPOSE: To report a case of Candida albicans endophthalmitis with no identifiable predisposing risk factors. CASE REPORT: A 57-year-old male presented with a 3-day history of worsening floaters and reduced visual acuity. Fundoscopy and optical coherence tomography showed presence of fluffy white preretinal and intraretinal infiltrates. With no past medical history or evidence of immunosuppression but having travelled abroad and suffered from diarrhoea, fungal aetiology was thought to be unlikely and as a result, treatment was commenced for toxoplasma. Despite treatment, his vision did not improve. Initial investigations including inflammatory markers, serology for toxoplasmosis, blood culture, chest radiograph and aqueous sampling could not identify a source of infection. However, polymerase chain reaction results from vitreous sampling revealed C. albicans. As a result, the patient was treated with intravenous voriconazole and intravitreal amphotericin B. As initial clinical improvement was limited, a vitrectomy was performed with further intravitreal amphotericin B. Clinical improvement was rapid following vitrectomy. After repeated Gram staining and culture of infected toenails, Gram-positive yeast cells were isolated.
CONCLUSION: Although C. albicans is a frequent cause of endogenous endophthalmitis, patients often have one or more predisposing systemic condition assisting the diagnosis. The present case illustrates that (1) even in the absence of any predisposing risk factors, C. albicans should be considered as a possible differential diagnosis in recalcitrant uveitis, and (2) endogenous candida endophthalmitis can be a result of fungal infections from distant sites such as the toenails.

Entities:  

Keywords:  Amphotericin B; Candida albicans; Endophthalmitis; Voriconazole

Year:  2012        PMID: 23275788      PMCID: PMC3530141          DOI: 10.1159/000342135

Source DB:  PubMed          Journal:  Case Rep Ophthalmol        ISSN: 1663-2699


Introduction

Candida endophthalmitis is a potentially devastating ocular condition. It presents as a complication in 9–45% of all cases of candidaemia (commonly with Candida albicans), associated with well-known predisposing risk factors such as intravenous drug abuse, immunodeficiency, prolonged systemic corticosteroid or antibiotic therapy, cytotoxic chemotherapy and long-term parenteral feeds [1, 2]. In rare cases of endogenous infection with no presdisposing risk factors, diagnosis and justification for use of intravitreal antifungal agents can be difficult [3]. This is a case report describing the management of a patient with endogenous endophalmitis due to C. albicans which was not associated with any of the known predisposing factors of candidaemia. The report demonstrates the development of a differential diagnosis in an atypical scenario, the eventual confirmation of the infective agent from vitreous sampling and also the identification of the possible source of the Candida organism leading to the justification for an aggressive antifungal regimen which resulted in a good outcome.

Case Report

A 57-year-old male presented with a 3-day history of blurred vision, floaters and reduced visual acuity to 6/9 in his left eye. His right eye was asymptomatic with a visual acuity of 6/5. Ocular examination of the left eye showed inflammatory activity in the anterior and posterior segments with mild anterior uveitis and vitritis along with several fluffy white retinal infiltrates near the foveal centre (fig. ). The right eye was completely normal. An optical coherence tomography (OCT) scan confirmed the presence of vitreous and intraretinal infiltrates (fig. ). Further clinical evaluation revealed that the patient had been fit and well but had a brief episode of diarrhoea several weeks earlier whilst visiting the Canary Islands, Spain, and he also had developed signs of toenail infection affecting several toes over the previous 6 months. He was not on any medication and there was no history of other illness, intravenous drug abuse or any opportunistic infections to suggest immunosuppression. Clinical suspicion at this stage was of infective retinitis due to fungal infection or toxoplasmosis. Because the patient was not immunocompromised, a fungal aetiology was felt to be less likely and he was commenced on oral azithromicin 500 mg once a day and hourly topical dexamethasone 0.1%. As this was an empirical treatment, an extensive uveitis screen was performed, but all of these initial tests were normal or negative, including chest X-ray, haematological profile, ESR, CRP, serum ACE level, serology for toxoplasma and VDRL as well as HIV. Polymerase chain reaction (PCR) analysis of aqueous was also negative for toxoplasma, CMV, VZV, HSV, Mycobacterium, Candida and fungal RNA. Blood cultures and cultures of nail clippings from his infected toenails were negative. After 1 week of follow-up, the patient had worsened considerably with increasing vitritis and vitreous infiltrates at the vitreoretinal interface causing a reduction in vision to 6/60 (fig. 1b). At this point, the decision was made to carry out diagnostic vitreous biopsy. An automated vitrector was used to obtain a vitreous biopsy and samples were sent for PCR analysis and microbiological testing. From this sample, PCR analysis was positive for C. albicans DNA, which was confirmed several weeks later by a positive culture.
Fig. 1

Fundus photographs of the patients' left eye showing fluffy white retinal and vitreous infiltrates at presentation (a), 1 week after presentation (b) and after surgery (c).

Following confirmation of Candida DNA on PCR analysis of the vitreous sample, intravenous voriconazole 400 mg b.d. and intravitreal amphotericin B (5 μg/0.1 ml) was immediately commenced. After 7 days of systemic antifungal therapy with the above regimen, there was very little treatment response and hence a 3-port pars plana vitrectomy was performed and intravitreal administration of amphotericin B (5 μg/0.1 ml) was repeated. Diagnostic sampling was repeated on this occasion and although PCR analysis was negative for Candida DNA from the second vitrectomy sample, culture yielded positive growth and histopathological analysis showed typical yeast-like organisms with the classical budding pattern appearance (fig. ). The further confirmation of Candida on a second vitreous biopsy justified continuing antifungal therapy with oral voriconazole (200 mg b.d.). The confirmation of the source of the endogenous candida endophthalmitis came much later when repeated samples of nail clippings eventually detected Gram-positive yeast cells 30 days after the initial presentation. The patient improved following the vitrectomy and there were no signs of vitreous infiltrates (fig. 1c) after 1 week and OCT showed minimal residual intraretinal oedema (fig. 2b). After further 2 months of follow-up, his vision had improved to 6/9 with complete resolution of retinal oedema.
Fig. 2

OCT of the patients' left eye showing intraretinal, preretinal and vitreous infiltrates with vitritis (top). One week following vitrectomy, no retinal or vitreous infiltrates and presence of residual intraretinal oedema were observed (bottom).

Discussion

The diagnostic approach in this case was influenced by a strong, pretest clinical suspicion of an underlying infective aetiology due to the absence of systemic inflammatory signs, cellular infiltration in both anterior and posterior segments, unilateral involvement and the presence of focal infiltration in the posterior vitreous and anterior retinal layers [4]. The organisms involved in cases of infective uveitis depend largely on whether the patient is immunocompromised or immunocompetent. Fungal and infections by other opportunistic pathogens are much more likely to occur in immunocompromised individuals [3]. C. albicans is the most common cause of endogenous endophthalmitis and frequently presents as a unilateral posterior uveitis associated with fluffy white vitreous and retinal infiltrates which have often been described as a ‘string of pearls’ appearance. It almost always occurs in patients who are immunocompromised or have other predisposing risk factors such as intravenous drug abuse [2, 3]. Although our patient had a very typical fundus appearance suggestive of fungal endophthalmitis, it was very unusual in that he was immunocompetent and had no apparent risk factors. In the world literature, there are only two case reports of endogenous candida endophthalmitis with no previous predisposing risk factors [5, 6]. The first case was a patient with onychomycosis and vaginal candidiasis [5]. The culture for the same strain of Candida was positive for the nail and the eye. The second case had used inhaled steroids for asthma and could have developed asymptomatic oropharyngeal candidiasis [6]. From these reported cases and the experience in our case, it appears that endogenous candida endophthalmitis could occur from mild fungal infections from a distant site such as the toenail. Another interesting and unexpected finding in this case was the negative PCR result from the vitreous sample taken at the second vitrectomy when this specimen eventually grew Candida on culture. This paradoxical disconnect between PCR and culture results has been reported before, especially in association with repeated sampling. Harper et al. [7] analysed all PCR results of aqueous and vitreous samples in diagnosis of infectious uveitis and concluded that specimens from the first week of presentation (acute stage) were more likely to have positive PCR results than those sampled later. Harper et al. [7] postulate polymorphism and specimen degradation as possible causes of false-negative results. In our case, two vitreous samples were performed. The first yielded positive PCR, but a positive growth on culture took over 3 weeks by which time the second vitrectomy had been performed. The second vitreous sample yielded a negative PCR, but yeast-like organisms were identifiable on histopathology and growth was also positive on culture. This illustrates that confirmation of Candida as the causative agent can be difficult as PCR and Gram stain can be falsely negative and culture can take several weeks to yield any diagnostic growth. Reported cases of endogenous endophthalmitis due to C. albicans tend to have a poor visual outcome [8]. Our case had a good visual outcome despite the infiltrate being located very close to the fovea. The factors contributing to the good outcome in this case were probably the early intervention with a second vitrectomy and intravitreal amphotercin B, the continuation of prolonged course of oral voriconazole and also the immunocompetent status of our patient. Systemic antifungal drugs such as fluconazole, voriconazole and amphotericin B given intravenously or orally are indicated in disseminated candidaemia. We chose to use voriconazole as a first-line antifungal for its broad spectrum activity as we did not have confirmation of Candida on the vitreous culture initially and blood cultures were negative. Several reports have suggested early vitrectomy, especially in lesions affecting the macula or significant vitritis. Advantages are thought to be reduction of infectious load, increase in intraocular diffusion of systemically administered medication and reduction of the risk of retinal detachment by limiting vitreoretinal traction [9, 10]. For these multiple potential benefits, we felt it was justified to perform a vitrectomy and allowed the intravitreal administration of amphotericin B (5 μg/0.1 ml) which tends to have poor ocular penetration when given systemically [11, 12]. In summary, this interesting case illustrates that endogenous endophthalmitis due to C. albicans is rare but can occur in patients with no predisposing risk factors or evidence of candidaemia. In these situations, when the clinical findings suggest a fungal aetiology, repeated diagnostic testing with a combination of PCR, Gram staining and culture of vitreous and suspected primary sites of infection can be helpful in confirming the definitive diagnosis and provide confidence for adherence to a prolonged course of systemic antifungal therapy to achieve eradication of the organism and a good visual outcome.
  10 in total

1.  Endogenous endophthalmitis caused by Candida albicans in a healthy woman.

Authors:  D A Kostick; R E Foster; C Y Lowder; S M Meyers; M C McHenry
Journal:  Am J Ophthalmol       Date:  1992-05-15       Impact factor: 5.258

2.  Candida glabrata endophthalmitis treated successfully with caspofungin.

Authors:  Juan C Sarria; Jay C Bradley; Ranya Habash; Kelly T Mitchell; Robert C Kimbrough; Ana M Vidal
Journal:  Clin Infect Dis       Date:  2005-02-01       Impact factor: 9.079

3.  Endogenous Candida endophthalmitis with no apparent predisposing factors.

Authors:  R M Stanbury; A H Chignell; E M Graham
Journal:  Eye (Lond)       Date:  1998       Impact factor: 3.775

Review 4.  Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents.

Authors:  James Riddell; Grant M Comer; Carol A Kauffman
Journal:  Clin Infect Dis       Date:  2011-01-16       Impact factor: 9.079

5.  Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis due to Candida albicans.

Authors:  A Louie; W Liu; D A Miller; A C Sucke; Q F Liu; G L Drusano; M Mayers; M H Miller
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

6.  Relation between stage of endogenous fungal endophthalmitis and prognosis.

Authors:  Hiroshi Takebayashi; Atsushi Mizota; Minoru Tanaka
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-12-06       Impact factor: 3.117

7.  Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes.

Authors:  Vivian Schiedler; Ingrid U Scott; Harry W Flynn; Janet L Davis; Matthew S Benz; Darlene Miller
Journal:  Am J Ophthalmol       Date:  2004-04       Impact factor: 5.258

8.  Intraocular penetration of systemically administered antifungal agents.

Authors:  D M O'Day; W S Head; R D Robinson; W H Stern; J M Freeman
Journal:  Curr Eye Res       Date:  1985-02       Impact factor: 2.424

9.  Polymerase chain reaction analysis of aqueous and vitreous specimens in the diagnosis of posterior segment infectious uveitis.

Authors:  Thomas W Harper; Darlene Miller; Joyce C Schiffman; Janet L Davis
Journal:  Am J Ophthalmol       Date:  2008-10-02       Impact factor: 5.258

10.  Factors determining visual outcome in endogenous Candida endophthalmitis.

Authors:  Ahmed Sallam; Simon R J Taylor; Aldrin Khan; Peter McCluskey; William A Lynn; Kiran Manku; Patricio A Pacheco; Sue Lightman
Journal:  Retina       Date:  2012-06       Impact factor: 4.256

  10 in total
  4 in total

Review 1.  Third case of Candida dubliniensis endogenous endophthalmitis in North America: case report and review of the literature.

Authors:  Elizabeth Rosenberger; Dima A Youssef; Sara Safdar; Cristoforo R Larzo; James Myers
Journal:  Int Ophthalmol       Date:  2014-08       Impact factor: 2.031

2.  Anterior and pan-endophthalmitis caused by Candida albicans and Aspergillus fumigatus: report of two cases.

Authors:  Anan Wang; Jianxiong Cao; Shufang Hu; Zhenquan Zhao; Mingling Wang; Tianlin Xiao
Journal:  Mycopathologia       Date:  2013-08-15       Impact factor: 2.574

3.  Systemic Candida albicans Infection in Mice Causes Endogenous Endophthalmitis via Breaching the Outer Blood-Retinal Barrier.

Authors:  Sneha Singh; Sukhvinder Singh; Ashok Kumar
Journal:  Microbiol Spectr       Date:  2022-08-01

4.  Multimodal imaging of refractory Candida chorioretinitis progressing to endogenous endophthalmitis.

Authors:  Jeremy A Lavine; Mihai Mititelu
Journal:  J Ophthalmic Inflamm Infect       Date:  2015-08-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.